Loading
No insider purchase over the last 90 days. The latest, by 秦学玲, was filed 31 Aug 2022.
Sichuan Hebang Biotechnology Corporation Limited: what insiders have been doing
Sichuan Hebang Biotechnology Corporation Limited has a thin disclosure history in our data (latest filing: 31 August 2022). New filings will appear here as soon as they are published. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€2,249
1 ops. · all time
Sell Volume
n/a
n/a
Since the insiders bought
- -36.4%Entry CN¥3.76 · Close at T+365 CN¥2.39
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 24,761 of 26,320 companies
16.7
score / 100
Value20
Quality14
FCF yld-1.0%
Earn yld-2.9%
EV/EBITDA53.8x
ROE-2.0%
Gross mgn12%
Net mgn-7.5%
Debt/EBITDA17.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥2.19
Analyst consensus
Income statement
RevenueCN¥7.2B
Gross profitCN¥828M12% margin
EBITDACN¥507M7% margin
Net income-CN¥536.4M-3.4% margin
Valuation
P/Book1.0x
Beta0.51
Balance sheet & cash
Market capCN¥19.3B
Total debtCN¥8.7B
Free Cash Flow-CN¥182.7M
Debt / Equity46%
Profitability & ownership
ROE-2.0%
ROA0.6%
% insiders38.4%
% institutions2.1%
Last declaration on 31 August 2022
Declarations1 total
4,100 shares100.0% of flowA股XSHGSSE:173000005850986500
Canonical exit: 29 Nov 2022 (T+90)
1 of 1 declaration
About Sichuan Hebang Biotechnology Corporation Limited
和邦生物 is a company specializing in the chemical and materials sector. It is listed on the Shanghai Stock Exchange (XSHG).
